Emergent BioSolutions, Inc. (EBS)
11.21
+0.22
(+2.00%)
USD |
NYSE |
Jan 20, 13:43
Emergent BioSolutions EPS Diluted (Quarterly): 0.9062 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.5048 |
| Eli Lilly & Co. | 6.211 |
| Penumbra, Inc. | 1.167 |
| Disc Medicine, Inc. | -1.772 |
| Black Diamond Therapeutics, Inc. | -0.1493 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 51.20M |
| Revenue (Quarterly) | 231.10M |
| Total Expenses (Quarterly) | 179.90M |
| Enterprise Value | 998.99M |
| Gross Profit Margin (Quarterly) | 55.86% |
| Profit Margin (Quarterly) | 22.15% |
| Earnings Yield | 11.54% |
| Operating Earnings Yield | 18.63% |
| Normalized Earnings Yield | 11.26 |